Lv, F., Si, W., Xu, X., He, X., Wang, Y., Li, Y., & Li, F. (2024). RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells. Elsevier.
Chicago Style (17th ed.) CitationLv, Fengxu, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, and Feifei Li. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.
MLA citiranjeLv, Fengxu, et al. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.
Opozorilo: Ti citati niso vedno 100% točni.